rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2007-7-31
|
pubmed:abstractText |
Studies evaluating predictors of tPA-associated symptomatic intracerebral hemorrhage (SICH) have typically focused on clinical and CT-based variables. MRI-based variables have generally not been included in predictive models, and little is known about the influence of reperfusion on SICH risk.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1524-4628
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2275-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17569874-Acute Disease,
pubmed-meshheading:17569874-Aged,
pubmed-meshheading:17569874-Aged, 80 and over,
pubmed-meshheading:17569874-Brain,
pubmed-meshheading:17569874-Cerebral Arteries,
pubmed-meshheading:17569874-Cerebral Hemorrhage,
pubmed-meshheading:17569874-Cerebrovascular Circulation,
pubmed-meshheading:17569874-Female,
pubmed-meshheading:17569874-Humans,
pubmed-meshheading:17569874-Iatrogenic Disease,
pubmed-meshheading:17569874-Magnetic Resonance Imaging,
pubmed-meshheading:17569874-Male,
pubmed-meshheading:17569874-Predictive Value of Tests,
pubmed-meshheading:17569874-Prospective Studies,
pubmed-meshheading:17569874-Regression Analysis,
pubmed-meshheading:17569874-Reperfusion Injury,
pubmed-meshheading:17569874-Risk Factors,
pubmed-meshheading:17569874-Stroke,
pubmed-meshheading:17569874-Thrombolytic Therapy,
pubmed-meshheading:17569874-Time Factors,
pubmed-meshheading:17569874-Tissue Plasminogen Activator
|
pubmed:year |
2007
|
pubmed:articleTitle |
Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
|
pubmed:affiliation |
Stanford University, Stanford Stroke Center, Palo Alto, California 94304, USA. Lansberg@stanford.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|